Laverock Therapeutics
PrivateLast Round
Grant
Jun 1, 2026
Total Funding Raised
$30.86M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Laverock Therapeutics is a biotechnology company that develops a gene silencing platform designed to engineer programmable and adaptive cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Laverock Therapeutics Comparables
Compare Laverock Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Concinnity Genetics | 82% | |
| Epigenic Therapeutics | 79% | |
| CellOrigin Biotech | 79% |
Laverock Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2026 | ||||
| Seed | Jun 30, 2025 | ||||
| Grant | Oct 30, 2023 | ||||
| Seed | Sep 28, 2023 |
Key People
Founding team and executive leadership
Laverock Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Future Planet Capital Regional | Seed, Grant |
| Mercia Ventures | Seed |
| Tekfen Ventures | Seed |
| Innovate UK | Grant |
| UK Innovation & Science Seed Fund | Grant |
| Calculus Capital | Seed |
| Eos Advisory | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 1199% MoM to 1.8K.
- Jun 1, 2026
Secured $3M in grant funding.
Laverock Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Laverock Therapeutics's valuation, stock price, and market status.
Is Laverock Therapeutics a public or private company?
Laverock Therapeutics is a private company.
What is the current stock price of Laverock Therapeutics?
Laverock Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Laverock Therapeutics worth (valuation)?
Valuation information for Laverock Therapeutics is not publicly available.
Can I buy Laverock Therapeutics stock?
Laverock Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Laverock Therapeutics's last funding round?
Laverock Therapeutics's most recent funding round was Seed on June 30, 2025.
Who are the main investors in Laverock Therapeutics?
Key investors in Laverock Therapeutics include Innovate UK, Calculus Capital.
Will Laverock Therapeutics IPO soon?
No public IPO plans have been announced for Laverock Therapeutics.
How can I track Laverock Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Laverock Therapeutics's secondary market activity and sign up for updates.